Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
The HIV/HCV-Coinfected Patient and New Treatment Options
Marie Louise C. Vachon
,
Douglas T. Dieterich
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Liver Diseases
Hepatology Transplant Fellowship Program
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The HIV/HCV-Coinfected Patient and New Treatment Options'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Co-infected Patients
100%
New Treatment Options
100%
HIV-HCV
100%
Standard of Care
66%
HCV Treatment
66%
Hepatitis C
33%
Drug Interactions
33%
Treatment Complexity
33%
Difficult-to-treat
33%
Direct-acting Antivirals
33%
Telaprevir
33%
Resistant mutants
33%
HIV Antiretrovirals
33%
Cusp
33%
Boceprevir
33%
Predictive Factors of Response
33%
Rapid Selection
33%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Treatment Option
100%
Hepatitis C
25%
Predictive Factor
25%
Drug Interaction
25%
Telaprevir
25%
Boceprevir
25%
Antiviral Drug
25%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hepatitis C
25%
Antiviral Drug
25%
Drug-Drug Interaction
25%
Telaprevir
25%
Boceprevir
25%